The Making Of An Oncologist: A Commitment to Lifelong Learning
Only a small percentage of future clinicians and researchers become fellows at prestigious universities, but those who do tend to have an outsized impact on the field. That’s certainly the case with NYU Langone’s clinical science fellowships.
“The unique level of training that our fellowships offer produces outstanding clinicians who do outstanding research,” says Lawrence B. Gardner, MD, associate professor of Medicine in the Division of Hematology and Medical Oncology, and director of NYU Langone’s Hematology/Medical Oncology Fellowship Program. Ensuring the future of cancer care means training tomorrow’s leaders today.
Fellowships at NYU Langone are typically intensive, three-year programs that combine the steep learning curve and constant demands of clinical responsibilities in an advanced specialty with a cutting-edge research project that aims to extend the boundaries of the field.
Two fellowships at NYU Langone widely recognized for the outstanding clinician- scientists they turn out are the Hematology/Oncology Fellowship Program and the Pediatric Hematology/Medical Oncology Training Program. The research component linked to both of these fellowships is partially funded by a highly competitive T32 grant from the National Institutes of Health.
Bernard and Irene Schwartz to fund new GI Oncology Fellowship Program
Soon joining the Perlmutter Cancer Center’s Hematology/ Medical Oncology Fellowship and Pediatric Hematology/ Oncology Training Program will be a third highly competitive fellowship: The Bernard and Irene Schwartz Gastrointestinal Oncology Fellowship Program. This GI fellowship will be among the first in the country dedicated to training physician-scientists in gastrointestinal cancer research—cancers that take more lives each year than any other group of tumors.
The fellowship builds on NYU Langone’s longstanding leadership in research and treatment of GI malignancies, and will focus on training future physician-scientists to help produce innovative new therapies for these challenging cancers. Among the many promising, pioneering avenues of research at NYU Langone on which trainees might choose to focus are the pancreatic cancer tumor microenvironment; the molecular basis of cancer development; the bacteria and viruses that influence the onset of GI cancers; and gastrointestinal inflammations that can lead to cancer.
As with the other two fellowships, the physician trainees in the new GI program will leave it well-positioned to continue toward a leadership position in the field, including: heading a translational oncology laboratory; leading innovative clinical trials; or developing a population science program.
Three trainees will be enrolled each year, based on one primary criteria: an unwavering commitment to a career as a cancer physician-scientist.
The new fellowship has been made possible by a generous gift from Bernard and Irene Schwartz. “My family owes a great deal to the expertise and devotion of leading physicians at NYU,” said Mr. Schwartz. “Irene and I are fortunate to be in a position to support the institution as it helps produce a new generation of top physician-researchers in this important area of medicine.”